öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÕÅÓî
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º64

ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©¼Áѧ¡¢Ò©Ñ§£¨Ò©¼Áѧ·½Ïò£©


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºzywinner01@163.com
ͨѶµØÖ·£ºÁÉÄþÊ¡±¾Ïª¸ßм¼Êõ²úÒµ¿ª·¢Çø»ªÙ¢´ó½Ö26ºÅ


¸öÈ˼òÊö :
ÕÅÓÄУ¬²©Ê¿£¬¸±½ÌÊÚ£¬2005Äê±ÏÒµÓÚÉòÑôÒ©¿Æ´óѧ£¬»ñÀíѧѧʿѧ룬2010Äê»ñÉòÑôÒ©¿Æ´óѧҩ¼Áѧ²©Ê¿Ñ§Î»£¬ 2011ÄêÆðÁôУ´ÓʽÌѧÓë¿ÆÑй¤×÷£¬2015Ä걻ֱƸΪÉòÑôÒ©¿Æ´óѧҩ¼ÁöλÔÓéÀֵǼÈë¿ÚÏÂÔظ±½ÌÊÚ£¬2016ÄêÔÚÓ¢¹úŵºº¶¡´óѧҩѧԺ×÷Ϊ·ÃÎÊѧÕß½øÐÞÒ»Ä꣬µ¼Ê¦ÊǸ߷Ö×Ó²ÄÁÏÁìÓòÖøÃûµÄCameron Alexander½ÌÊÚ¡£Ä¿Ç°×÷Ϊ¿ÎÌ⸺ÔðÈËÖ÷³ÖÁ˹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ðÏîÄ¿Ò»ÏÖ÷³ÖÁÉÄþÊ¡²©Ê¿Æô¶¯»ù½ðÏîÄ¿Ò»ÏÖ÷³ÖÖйú²©Ê¿ºó¿Æѧ»ù½ðÌرð×ÊÖúÏîÄ¿Ò»ÏÖ÷³ÖÖйú²©Ê¿ºó¿Æѧ»ù½ðÏîÄ¿Ò»ÏÖ÷³ÖÁÉÄþÊ¡½ÌÓýÌüÒ»°ãÏîÄ¿Ò»Ï×÷Ϊ¹Ç¸É³ÉÔ±²ÎÓëÁËÊ®¶þÎ塢ʮһÎåÖØ´óÐÂÒ©´´ÖƵÈÊ¡²¿¼¶ÒÔÉÏÏîÄ¿8Ïî¡£³ý¹ú¼Ò¡¢Ê¡ÊпÎÌâÍ⣬×÷Ϊ¹Ç¸É³ÉÔ±¸ºÔðÁ˶àÖÖ´´ÐÂÒ©ÎïµÄ¿ª·¢¼°É걨¹¤×÷¡£ÉêÇë·¢Ã÷רÀû22ÏÆäÖÐ11Ïî»ñµÃרÀûÊÚȨ£¨PCTרÀû1Ï£¬×¨ÀûתÈÃ1Ï¶à´ÎÈÙ»ñÁÉÄþÊ¡¿Æ¼¼½ø²½½±£¬ÉòÑôÊпƼ¼½ø²½½±£¬ÁÉÄþÊ¡×ÔÈ»¿ÆѧѧÊõ³É¹û½±£¬ÉòÑôÊÐ×ÔÈ»¿ÆѧѧÊõ³É¹û½±£¬ËùÉæ¼°µÄ¿ÎÌâ²úÉúÁËÁ¼ºÃµÄ¾­¼ÃЧÒæºÍÉç»áЧÒæ¡£´ËÍ⣬2014Äê¶ÈÈëÑ¡µÚ¶þÅú¡°½­ËÕÊ¡²©Ê¿ºó¿ÆÑÐ×ÊÖú¼Æ»®¡±£¬½­ËÕÊ¡¡°Ë«´´¼Æ»®¡±ÒÔ¼°ÉòÑôÒ©¿Æ´óѧÖÐÇàÄê½ÌʦÊÂÒµ·¢Õ¹Ö§³Ö¼Æ»®£¬2015ÄêÈëÑ¡¡°ÁÉÄþÊ¡°ÙǧÍòÈ˲Ź¤³ÌÍòÈ˲ã´Î¡±£¬2017ÄêÈëÑ¡¡°ÁÉÄþÊ¡°ÙǧÍòÈ˲Ź¤³ÌǧÈ˲ã´Î¡±¡£·¢±íSCIÂÛÎÄ70Óàƪ£¬ÆäÖеÚÒ»×÷Õß»òͨѶ×÷Õß12ƪ£¬µÚ¶þ×÷Õß11ƪ£»²ÎÒëרÖø¡¶ÖƼÁ¹¤ÒÕ·Å´ó¡·¡£

¿ÆÑй¤×÷ :
½üÄêÀ´·¢±í´ú±íÐÔÂÛÎÄ(ÏÞµÚÒ»×÷Õß»òͨѶ×÷Õߣ¬SCIÐëдÃ÷Ó°ÏìÒò×Ó)£º1. Zhang Y*, Ren T, Gou J, Zhang L, Tao X, Tian B, Tian P, YuD, Song J, Liu X, Chao Y, Xiao W, Tang X*. Strategies for improving the payloadof small molecular drugs in polymeric micelles [J]. J Control Release, 2017.(IF=7.441)2. Liu X, Han M, Xu J, Geng S, Zhang Y*, Ye X,Gou J, Yin T, He H, Tang X*. Asialoglycoprotein receptor-targeted liposomesloaded with a norcantharimide derivative for hepatocyte-selective targeting[J]. Int J Pharm, 2017, 520(1-2): 98-110. (IF=3.994)3. Geng S, Liu X, Xu H, Cai C, Zhang Y*, Yao Q,Xu H, Gou J, Yin T, Xiao W. Clarithromycin ion pair in a liposomal membrane toimprove its stability and reduce its irritation caused by intravenousadministration [J]. Expert Opinion on Drug Delivery, 2016, 13(3): 1-12.(IF=5.434)4. Zhang L, Tian B, Li Y, Lei T, Meng J, Yang L, ZhangY*, Chen F, Zhang H, Xu H, Tang X*. A Copper-Mediated Disulfiram-LoadedpH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use inTumor Therapy [J]. ACS applied materials & interfaces, 2015, 7(45):25147-25161.(IF=7.145)5. Zhang Y, Hu X, Liu X, Dandan Y, Di D, Yin T, Zhang S, TangX*. Dry state microcrystals stabilized by an HPMC film to improve thebioavailability of andrographolide [J]. Int J Pharm, 2015, 493(1-2):214-223.(IF=3.994)6. Fang G, Tang B, Chao Y, Zhang Y*, Xu H, TangX*. Improved oral bioavailability of docetaxel by nanostructured lipid carriers:in vitro characteristics, in vivo evaluation and intestinal transport studies[J]. RSC Advances, 2015, 5(117): 96437-96447.(IF=3.289)7. Zhang Y, Gou J, Sun F, Geng S, Hu X, Zhang K, Lin X, XiaoW, Tang X*. Impact of electrolytes on double emulsion systems (W/O/W)stabilized by an amphiphilic block copolymer [J]. Colloids Surf BBiointerfaces, 2014, 122C: 368-374.(IF=3.902)8. Zhang L, Jiang Y, Jing G, Tang Y, Chen X, Yang D,Zhang Y*, Tang X*. A novel UPLC-ESI-MS/MS method for the quantitation of disulfiram,its role in stabilized plasma and its application [J]. J Chromatogr B AnalytTechnol Biomed Life Sci, 2013, 937: 54-9. (IF=2.687)9. Zhang Y, Wang X, Lin X, Liu X, Tian B, Tang X*. Highazithromycin loading powders for inhalation and their in vivo evaluation inrats [J]. Int J Pharm, 2010, 395(1-2): 205-14. (IF=3.994)10. Zhang Y, Tang X*, Liu X, Li F, Lin X. Simultaneousdetermination of three bufadienolides in rat plasma after intravenousadministration of bufadienolides extract by ultra performance liquidchromatography electrospray ionization tandem mass spectrometry [J]. Analyticachimica acta, 2008, 610: 224-231. (IF= 4.712)